2 results
Approved WMORecruiting
The study the safety and imaging characteristics of GE-137
Approved WMOWill not start
The primary objective is to determine the pharmacokinetic characteristics of galantamine after 2 single oral doses in children with Down syndrome. Secondary objectives are to evaluate safety and tolerability.